GMVD Key Statistics, Chart & Performance
The current stock price of GMVD is 0.181 USD. In the past month the price decreased by -46%. In the past year, price decreased by -98.57%.
GMVD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.72 | 101.94B | ||
| CI | THE CIGNA GROUP | 9.82 | 74.52B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 124.05 | 22.82B | ||
| LH | LABCORP HOLDINGS INC | 15.92 | 20.88B | ||
| DGX | QUEST DIAGNOSTICS INC | 17.87 | 19.40B | ||
| GH | GUARDANT HEALTH INC | N/A | 14.19B | ||
| DVA | DAVITA INC | 12.07 | 7.87B | ||
| HIMS | HIMS & HERS HEALTH INC | 58.69 | 7.21B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 36.79 | 6.77B | ||
| CHE | CHEMED CORP | 20.2 | 6.29B | ||
| RDNT | RADNET INC | 205.79 | 6.03B | ||
| OPCH | OPTION CARE HEALTH INC | 21.34 | 5.05B |
Related stock screener links
About GMVD
Company Profile
G Medical Innovations Holdings Ltd. operates as a mobile health and digital health company, which engages in the development and marketing clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for remote monitoring and telemedicine projects. The company is headquartered in George Town, Grand Cayman. The company went IPO on 2017-10-26. The firm is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. The company develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. The company also develops wireless vital signs monitoring systems.
Company Info
G MEDICAL INNOVATION HOLDING
P.O. Box 10008, Willow House, Cricket Square
GEORGE TOWN GRAND CAYMAN KY
Employees: 0
G MEDICAL INNOVATION HOLDING / GMVD FAQ
Can you describe the business of G MEDICAL INNOVATION HOLDING?
G Medical Innovations Holdings Ltd. operates as a mobile health and digital health company, which engages in the development and marketing clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for remote monitoring and telemedicine projects. The company is headquartered in George Town, Grand Cayman. The company went IPO on 2017-10-26. The firm is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. The company develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. The company also develops wireless vital signs monitoring systems.
What is the current price of GMVD stock?
The current stock price of GMVD is 0.181 USD.
Does GMVD stock pay dividends?
GMVD does not pay a dividend.
What is the ChartMill technical and fundamental rating of GMVD stock?
GMVD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What is the analyst forecast for GMVD stock?
7 analysts have analysed GMVD and the average price target is 4.08 USD. This implies a price increase of 2154.14% is expected in the next year compared to the current price of 0.181.
GMVD Technical Analysis
GMVD Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
GMVD Forecast & Estimates
7 analysts have analysed GMVD and the average price target is 4.08 USD. This implies a price increase of 2154.14% is expected in the next year compared to the current price of 0.181.